Jianghua Li

First-Line Osimertinib in Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Effectiveness, Resistance Mechanisms, and Prognosis of Different Subsequent Treatments

Yong He, Z. Ding, Li Li, 2022, Clinical Medicine Insights. Oncology.

The rational application of liquid biopsy based on next‐generation sequencing in advanced non‐small cell lung cancer

N. Yang, Yongchang Zhang, Yong He, 2022, Cancer medicine.

The mechanism of multiple organ dysfunction syndrome in patients with COVID‐19

Bin Xu, Jian Xu, Wen-yan Zhao, 2022, Journal of medical virology.

Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling

Y. Zhuang, Chen Hu, Xiaolin Tang, 2022, Communications Biology.

Melatonin Inhibits Annulus Fibrosus Cell Senescence through Regulating the ROS/NF-κB Pathway in an Inflammatory Environment

Lei Chen, Zhi Ruan, Sibo Wang, 2021, BioMed research international.

Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China.

Yalan Qin, Jiang-lin Xiang, E. Higgs, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China

Yalan Qin, Jiang-lin Xiang, E. Higgs, 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer

Yong He, Cheng Shen, Li Li, 2023, Cancer science.

Low BMI patients with advanced EGFR mutation-positive NSCLC can get a better outcome from metformin plus EGFR-TKI as first-line therapy: A secondary analysis of a phase 2 randomized clinical trial

Yubo Wang, Tingting He, Jie Zheng, 2023, Chinese medical journal pulmonary and critical care medicine.